ArticleBritish journal of pharmacology2002
Characterization of G proteins involved in activation of nonselective cation channels by endothelin(B) receptor.
Article in British journal of pharmacology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 9 citations in OpenAlex.
- Differences in Endothelin B Receptor Isoforms Expression and Function in Breast Cancer Cells.Journal of Cancer · 2020Article
- Endothelin-1 activation of ETB receptors leads to a reduced cellular proliferative rate and an increased cellular footprint.Experimental cell research · 2012Article
- Hyperforin activates nonselective cation channels (NSCCs).British journal of pharmacology · 2005Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
1: We recently demonstrated that endothelin-1 (ET-1) activates two types of Ca(2+)-permeable nonselective cation channels (NSCC-1 and NSCC-2) in Chinese hamster ovary cells expressing endothelin(B) receptors (CHO-ET(B)R) that couple with G(q) and G(i). The purpose of the present study was to identify the G proteins involved in the activation of these Ca(2+) channels by ET-1. For this purpose, we constructed CHO cells expressing an unpalmitoylated (Cys(402)Cys(403) Cys(405)-->Ser(402)Ser(403)Ser(405)) ET(B)R (CHO-SerET(B)R) and ET(B)R truncated at the cytoplasmic tail downstream of Cys(403) (CHO-ET(B)RDelta403). 2: Based on the data obtained from actin stress fibre formation, CHO-ET(B)R couple with G(13). Therefore, CHO-ET(B)R couple with G(q), G(i) and G(13). CHO-SerET(B)R and CHO-ET(B)RDelta403 couple with G(13) and G(q), respectively. 3: ET-1 activated NSCC-1 in CHO-ET(B)R preincubated with phospholipase C (PLC) inhibitor, U73122, and in CHO-SerET(B)R. On the other hand, ET-1 failed to activate Ca(2+) channels in CHO-ET(B)RDelta403. Microinjection of dominant negative mutants of G(13) (G(13)G225A) abolished activation of NSCC-1 and NSCC-2 in CHO-ET(B)R and that of NSCC-1 in CHO-SerET(B)R. 4: Y-27632, a specific Rho-associated kinase (ROCK) inhibitor, did not affect the ET-1-induced transient and sustained increase in [Ca(2+)](i) in CHO-ET(B)R. 5: These results indicate that (1) the cytoplasmic tail downstream of the palmitoylation sites of ET(B)R, but not the palmitoylation site itself, is essential for coupling with G(13), (2) the activation mechanism of each Ca(2+) channel by ET-1 is different in CHO-ET(B)R. NSCC-1 activation depends on G(13)-dependent cascade, and NSCC-2 activation depends on both G(q)/PLC- and G(13)-dependent cascades. Moreover, ROCK-dependent cascade is not involved in the activation of these channels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.